Clinical Trials Directory

Trials / Unknown

UnknownNCT03342131

Serum Concentration of Wnt2 and Wnt4 in Patients With Acute Coronary Syndrome

Change of Serum Wnt2 or Wnt4 and the Relationship With Hs-CRP,cTnI and Prognosis in Patients With Acute Coronary Syndrome

Status
Unknown
Phase
Study type
Observational
Enrollment
450 (estimated)
Sponsor
The First Affiliated Hospital of Dalian Medical University · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers

Summary

This study aims to find the change of serum wnt effectory moleculars and the association with Hs-CRP,cTnI and Prognosis in Patients with Acute Coronary Syndrome.

Detailed description

It has been reported that wnt effecory moleculars (wnt2, wnt4, wnt11,wnt10b, DKK1, DKK2) increased in myocardium at acute phase after myocardium infarction in animal experiment. These moleculars can be detected in serum or plasma from human subjects. However, there is few relevant studies about wnt2 and wnt4 concentration in patients with acute coronary syndrome. This study valuates the serum wnt2 and wnt4 concentration in patients with acute coronary syndrome. It will possibly enable to find the relationship between serum wnt2 or wnt4 concentration and Hs-CRP, cTnI and prognosis in patients with Acute Coronary Syndrome.

Conditions

Interventions

TypeNameDescription
OTHERCirculating wnt 2 and wnt 4 concentrationBlood (150 each group) is obtained into ethylenediaminetetraacetic acid(EDTA) tubes from all subjects via antecubital venepuncture to explore circulating wnt 2 and wnt 4 concentration by ELISA. Continuous wnt2 and wnt4 concentration are measured in all patients with STEMI at 0 , 7days and 12 months after admission. Other patients with acute syndrome system are measured Wnt 2 and wnt4 only once within 24h after admission. Wnt2 and wnt4 concentration in Control group will be measured only once with 24h after admission.

Timeline

Start date
2017-09-29
Primary completion
2018-09-29
Completion
2019-03-29
First posted
2017-11-14
Last updated
2018-02-08

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03342131. Inclusion in this directory is not an endorsement.